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hondrocyte proliferation and differentiation requires
their attachment to the collagen type II–rich matrix
of developing bone. This interaction is mediated by
integrins and their cytoplasmic effectors, such as the integrin-
linked kinase (ILK). To elucidate the molecular mechanisms
whereby integrins control these processes, we have speciﬁ-
cally inactivated the ILK gene in growth plate chondrocytes
using the Cre-lox methodology. Mice carrying an ILK allele
ﬂanked by loxP sites (ILK-ﬂ) were crossed to transgenic
mice expressing the Cre recombinase under the control of
the collagen type II promoter. Inactivation of both copies of
the ILK-ﬂ allele lead to a chondrodysplasia characterized
by a disorganized growth plate and to dwarﬁsm. Expression
C
 
of chondrocyte differentiation markers such as collagen
type II, collagen type X, Indian hedgehog and the PTH-
PTHrP receptor was normal in ILK-deﬁcient growth plates.
In contrast, chondrocyte proliferation, assessed by BrdU or
proliferating cell nuclear antigen
 
 
 
labeling, was markedly
reduced in the mutant growth plates. Cell-based assays
showed that integrin-mediated adhesion of primary cultures
of chondrocytes from mutant animals to collagen type II
was impaired. ILK inactivation in chondrocytes resulted in
reduced cyclin D1 expression, and this most likely explains
the defect in chondrocyte proliferation observed when ILK
is inactivated in growth plate cells.
 
Introduction
 
Endochondral bone formation is a multistep process in which
the conversion of a cartilaginous model to bone leads to longi-
tudinal growth. This process starts with mesenchymal cells that
condense and differentiate into two types of cells: chondrocytes
that form cartilage elements and express specific molecular
markers, such as 
 
 
 
1(II) collagen (collagen type II), and peri-
chondrial cells that surround the cartilage model. Starting from
the center of the cartilage elements, chondrocytes undergo
several steps of maturation from proliferating chondrocytes,
forming characteristic orderly columns, to nonproliferating,
hypertrophic cells (Shum and Nuckolls, 2002). Hypertrophic
chondrocytes express the specific marker 
 
 
 
1(X) collagen
(collagen type X) (Linsenmayer et al., 1991). Hypertrophy of
these chondrocytes is associated with apoptosis, matrix calcifica-
tion, and vascular invasion, after which the calcified cartilage
will be removed and replaced by trabecular bone and bone
marrow. This sequential process of chondrocyte proliferation,
hypertrophy, and replacement by osteoblasts responsible for
longitudinal bone growth is retained at the extremities of long
bones and organized into the specialized structure known as the
growth plate (Poole, 1991). Although multiple extracellular
signaling  molecules have been implicated in the control of
chondrocyte proliferation and maturation (Karsenty and
Wagner, 2002), our understanding of the intracellular signal-
ing pathways involved in these processes remains incomplete.
Chondrocyte proliferation and differentiation requires an
integrin-mediated interaction with the collagen type II–rich
 
Address correspondence to René St-Arnaud, Genetics Unit, Shriners
Hospital for Children, 1529 Cedar Ave., Montréal, Québec, Canada
H3G 1A6. Tel.: (514) 282-7155. Fax: (514) 842-5581. 
E-mail: rst-arnaud@shriners.mcgill.ca
L. Terpstra’s present address is Dept. of Pediatric Endocrinology, Vrije
Universiteit University Hospital, 1007 MB Amsterdam, Netherlands.
Key words: integrin-linked kinase; chondrocytes; Cre-lox; cyclin D1;
gene targetingT
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
140 The Journal of Cell Biology 
 
|
 
 
 
Volume 162, Number 1, 2003
 
matrix of developing bone. After engagement with extracellu-
lar matrix components, integrin receptors signal via multiple
downstream effectors (Hynes, 2002), including integrin-
linked kinase (ILK)* (Hannigan et al., 1996; Wu and
Dedhar, 2001). The kinase activity of ILK is stimulated in a
phosphatidylinositol 3,4,5-trisphosphate–dependent man-
ner (Delcommenne et al., 1998) after engagement of inte-
grins and growth factor receptors (Wu and Dedhar, 2001).
Once activated, ILK can phosphorylate its downstream effec-
tors, which include protein kinase B (PKB)/Akt and glyco-
gen-synthase kinase (GSK)-3 (Delcommenne et al., 1998).
Ultimately, the ILK signaling cascade affects gene expression
and cell proliferation and survival. Overexpression of ILK po-
tentiates c-jun–dependent activating protein-1 transcrip-
tional activity (Troussard et al., 1999) and can also lead to
translocation of 
 
 
 
-catenin to the nucleus, which results in ac-
tivation of lymphocyte enhancer factor-1–dependent tran-
scription (Novak et al., 1998). Constitutive ILK expression,
or activation, has been shown to stimulate cyclin D1 expres-
sion (Radeva et al., 1997; D’Amico et al., 2000; Persad et al.,
2001b). In addition, unregulated ILK expression also pro-
motes anchorage-independent growth, fibronectin matrix as-
sembly, and tumorigenesis (Hannigan et al., 1996; Radeva et
al., 1997; Wu et al., 1998). Together, these results show that
ILK is a key effector of downstream integrin signaling and an
important regulator of gene expression and cellular activity.
Inactivation of the ILK gene in genetic model systems
such as 
 
Drosophila
 
 and 
 
Caenorhabditis elegans
 
 resulted in de-
fects similar to loss of integrin function (Zervas et al., 2001;
Mackinnon et al., 2002). To understand the role of ILK sig-
naling in the adhesion, proliferation, differentiation, and
function of cells from the growth plate and therefore in the
control of skeletal growth, we have specifically inactivated
the ILK gene in growth plate chondrocytes using the Cre-lox
methodology. Mice carrying an ILK allele flanked by loxP
sites (ILK-fl) were crossed to transgenic mice expressing the
Cre recombinase under the control of the collagen type II
promoter/enhancer.
We show that inactivation of both copies of the ILK-fl al-
lele lead to reduced chondrocyte proliferation and adhesion
and caused dwarfism. Cyclin D1 expression was markedly
reduced in ILK-null chondrocytes. Our results demonstrate
that ILK-mediated signaling is essential for chondrocyte
proliferation and growth plate structure and function.
 
Results
 
ILK expression in growth plate chondrocytes
 
We first examined ILK expression in chondrocytes using im-
munohistochemistry. The ILK protein was abundantly ex-
pressed in embryonic chondrocytes at embryonic day (E)14.5
and E16.5 (Fig. 1, A and B). Expression was maintained
in proliferating and prehypertrophic chondrocytes of the
growth plate from birth to adulthood (Fig. 1, C–E). ILK was
not expressed in hypertrophic chondrocytes at all ages exam-
ined (Fig. 1, D and E; unpublished data). Although adjacent
bone tissue generated background autofluorescence, no signal
was detected in chondrocytes under control staining condi-
tions (Fig. 1 F; unpublished data). This specific ILK expres-
sion pattern suggested a role for ILK-mediated signaling in
growth plate development and function. We studied this pu-
tative role by specifically inactivating the ILK gene in prolif-
erating, collagen type II–expressing chondrocytes using Cre-
mediated excision of a loxP-flanked (floxed) ILK locus.
 
Characterization of the Col2-Cre transgenic mice
 
To document the ability of the collagen type II gene pro-
moter driving Cre recombinase transgene
 
 
 
(Col2-Cre) to in-
duce specific recombination in chondrocytes, the Col2-Cre
mice were bred with the targeted gene trap strain, ROSA26
reporter (R26R) (Soriano, 1999). Cre-mediated recombina-
tion in R26R mice allows LacZ expression, which can
readily be monitored by LacZ staining. This was performed
in Col2-Cre;R26R transgenic newborn pups. LacZ staining
could be detected in the growth plate of all bones and in cos-
tochondral chondrocytes (Fig. 2, middle). Analysis of sec-
tions from bone tissue revealed LacZ staining in proliferat-
ing, collagen type II–expressing chondrocytes but not
in differentiated hypertrophic cells (Fig. 2, right). Immu-
 
*Abbreviations used in this paper: Col2-Cre, collagen type II gene pro-
moter driving Cre recombinase transgene; CREB, cyclic AMP response
element binding protein; DMEM, Dulbecco’s Minimal Essential Medium;
E, embryonic day; GSK, glycogen synthase kinase; Ihh, Indian hedgehog;
ILK, integrin-linked kinase; ILK-fl, ILK allele flanked by loxP sites;
PCNA, proliferating cell nuclear antigen; PKB, protein kinase B;
PTHR1, PTH-PTHrP receptor.
Figure 1. ILK protein expression pattern in chondrocytes. Indirect 
immunofluorescence staining of chondrocytes with anti-ILK antibody. 
ILK protein was detected in proliferating and prehypertrophic 
chondrocytes at E14.5 (A), E16.5 (B), and postnatal days 4 (C), 
21 (D), and 90 (3 mo, E). Background staining of chondrocytes was 
negligible, but bone tissue showed background autofluorescence (F). 
Bar, 100  m.T
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nostaining with anti-Cre antibodies also confirmed specific
expression of the Col2-Cre transgene in proliferating chon-
drocytes in the growth plate of transgenic animals (Fig. 3, B
and C). No staining was detected in any other tissue or in
R26R control mice (Fig. 2; unpublished data). Together,
these data indicate that the Col2-Cre transgene was specifi-
cally expressed in chondrocytes at levels allowing recombina-
tion at the ROSA26 locus.
 
Excision at the ILK locus
 
LoxP sites were inserted downstream from exons 4 and 12
at the ILK locus through homologous recombination in
embryonic stem cells (Fig. 3 A). This strategy should delete
all the kinase domain of ILK upon Cre-mediated excision
and create a null allele. By mating floxed ILK mice with
Col2-Cre transgenic mice, mice heterozygous for the re-
combined floxed ILK allele were generated (genotype: IL-
K
 
fl/
 
 
 
,Cre). These mice had no phenotype (Fig. 4 A) and
were fertile. They were backcrossed to the homozygous
floxed ILK mice to inactivate both ILK alleles by Cre-
mediated excision (genotype: ILK
 
fl/fl
 
,Cre). The ability of
Cre to recombine the floxed ILK allele was examined by
PCR analysis of tail genomic DNA, which contains a siz-
able proportion of chondrocytes. The 230-bp amplimer
corresponding to the excised floxed ILK allele was detect-
able in both ILK
 
fl/
 
 
 
,Cre and ILK
 
fl/fl
 
,Cre mice, indicating
that Cre was capable of recombining the loxP sites within
the ILK gene (Fig. 3 D).
The ILK protein was expressed at high levels in the pro-
liferating chondrocytes of the growth plate from wild-type
(Fig. 1) and ILK
 
fl/
 
 
 
,Cre mice (Fig. 3 E). Inactivation of
both copies of the floxed ILK allele caused a significant re-
duction of the expression of the ILK protein in proliferating
chondrocytes (Fig. 3 F). Since the efficiency of the Cre-
mediated excision varied between mutant animals of the
ILK
 
fl/fl
 
,Cre genotype, the expression levels of the ILK pro-
tein varied accordingly (unpublished data). The efficiency
of the recombination induced by Cre was estimated to be
Figure 2. Chondrocyte-specific Cre-mediated recombination at 
the ROSA26 reporter locus. The Col2-Cre transgenic strain (Col2-
Cre Tg) was crossed to the ROSA26 reporter (Rosa  / ) strain. 
Cre-mediated recombination allowed expression of the  -Gal gene, 
which was monitored using LacZ staining in newborns (left) and 
tissue sections (right). Bar, 500  m.
Figure 3. Targeted inactivation of ILK in chondrocytes. 
(A) Structure of the floxed ILK allele. Excision by the 
Cre recombinase deletes the kinase domain. (black 
triangles), loxP sites; E, exon; TAG, translational stop 
codon. (B and C) Cre expression in wild-type (B, ILK
fl/ ) 
and transgenic (C, ILK
fl/fl,Cre) littermates. Indirect 
immunofluorescence staining of growth plate from 
neonatal mouse femur with anti-Cre antibody. 
(D) Cre-mediated excision of the floxed ILK allele in 
chondrocytes. DNA was prepared from tail clippings 
and analyzed by PCR with appropriate primers. The 
wild-type (w.t.,1.9 kb), floxed (fl, 2.1 kb) and Cre 
excised (230 bp) bands are indicated. Genotypes of a 
representative litter are indicated above lanes 1–4. M, 
DNA size markers. (E and F) ILK protein expression. 
Indirect immunofluorescence staining of growth plate 
from neonatal mouse femur. Note strong ILK signal in 
proliferating wild-type chondrocytes (E) that express 
type II collagen and reduced ILK expression in
ILK
fl/fl,Cre chondrocytes (F). Bar, 100  m.T
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superior to 50%, closer to 75%. All ILK
 
fl/fl
 
,Cre mice showed
the same phenotype.
 
Dwarfism and chondrodysplasia in ILK
 
fl/fl
 
,Cre mice
 
Newborn ILK
 
fl/fl
 
,Cre mice were born with the expected
Mendelian ratio (unpublished data). Postnatal death oc-
curred sporadically, mostly due to cannibalism. Newborn
ILK
 
fl/fl
 
,Cre mutant mice were smaller than control litter-
mates, with a typical shortening of the forelimbs and the
hindlimbs (unpublished data). This smaller size was more
evident as the mice aged (Fig. 4 A). Mutant limbs were obvi-
ously shorter but not deformed when compared with control
littermates (Fig. 4 B). Other organs were not affected. The
long bones of ILK
 
fl/fl
 
,Cre mice were shorter than controls at
birth and at all ages examined. The divergence in size was
more evident in older animals (Fig. 4 C), confirming the
dwarfism phenotype.
At the histological level, ILK
 
fl/fl
 
,Cre mice showed moder-
ate chondrodysplasia. When the characteristic zones of
chondrocyte differentiation throughout the growth plate
(resting, proliferating, prehypertrophic, and hypertrophic)
were compared, the most remarkable effect was seen in the
proliferating zone; the other zones appeared to be less af-
fected. Low and high power micrographs of the toluidine
blue-stained growth plate from 18-d-old animals is shown in
Fig. 4. The proliferating zone of wild-type and ILK
 
fl/
 
 
 
,Cre
mice was normally organized in the characteristic orderly
columns (Fig. 4, D and F). However, the proliferating zone
of ILK
 
fl/fl
 
,Cre animals showed poor columnar organization
(Fig. 4, E and G). Also, the shape of the mutant proliferat-
ing chondrocytes appeared to be highly abnormal. Instead of
the normal typical flat shape (Fig. 4, D and F), mutant pro-
liferating chondrocytes were rounded (Fig. 4, E and G; also
Fig. 3, C and F).
The disorganized columnar organization of proliferating
and prehypertrophic chondrocytes in ILK
 
fl/fl
 
,Cre mutant an-
imals led to a more poorly structured hypertrophic zone.
This appeared more evident at the secondary site of ossifica-
tion (Fig. 4 E). The development and morphology of the
secondary ossification center will be examined in subsequent
studies. The size of the hypertrophic zone and the morphol-
ogy of the hypertrophic chondrocytes from ILK
 
fl/fl
 
,Cre mu-
tant mice appeared normal at the primary spongiosa (Fig. 4,
E and G), however, suggesting that chondrocyte differentia-
tion itself was not affected by the engineered ILK mutation.
 
Expression of chondrocyte differentiation markers
 
To confirm that chondrocyte differentiation was normal in
the absence of ILK, we analyzed the expression of chondro-
cyte differentiation markers using in situ hybridization. The
Figure 4. Reduced growth and abnormal growth 
plate structure after chondrocyte-specific inactivation 
of ILK. (A) Phenotypic appearance of ILK
fl/ ,Cre (wild-
type, left) and ILK
fl/fl,Cre (mutant, right) littermates at 18 d. 
(B and C) Reduced femur length after chondrocyte-
specific inactivation of ILK (B). Femurs were smaller 
at all ages examined, but the divergence in size was 
more evident in older animals (C). (D–G) Toluidine 
blue staining of distal femoral growth plate from control 
18-d-old mouse (D and F) and corresponding sample 
from mutant littermate (ILK
fl/fl,Cre, E and G). Note the 
perturbed columnar organization of the chondrocytes 
in the mutant sample. The disorganized arrangement 
of the chondrocytes at the secondary ossification 
center is also evident on the low power micrographs. 
Bars, 100  m.T
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expression of collagen type II, a marker of immature, pro-
liferating chondrocytes, and collagen type X, a marker
of hypertrophic chondrocytes, was first monitored in em-
bryonic long bones. At E16.5, chondrocytes from control
(ILK
 
fl/
 
 
 
,Cre) and mutant (ILK
 
fl/fl
 
,Cre) mice expressed 
 
 
 
1
(II) and 
 
 
 
1(X) collagen (Fig. 5, A–D). The size of the col-
lagen type II–expressing, proliferating, and prehypertrophic
chondrocyte zone was similar between the two genotypes
(Fig. 5, A and B). There was also no major change in the size
of the hypertrophic chondrocyte zone expressing collagen
type X (Fig. 5, C and D). The expression of collagen type II
and collagen type X was also confirmed by immunochemis-
try on postnatal days 4 and 18 (unpublished data).
The signaling molecule Indian hedgehog (Ihh) regulates
key events of skeletal morphogenesis, including chondrocyte
proliferation and maturation (St-Jacques et al., 1999). Ihh
expression is restricted to the prehypertrophic chondrocytes
in late embryogenesis (Bitgood and McMahon, 1995; St-
Jacques et al., 1999). This wild-type pattern of expression
was observed in ILK
 
fl/
 
 
 
,Cre embryos (Fig. 5 E) and was
not affected in ILK
 
fl/fl
 
,Cre mice (Fig. 5 F). Prehypertro-
phic chondrocytes also express the PTH-PTHrP receptor
(PTHR1) (Lanske et al., 1996). We observed no differences
in the PTHR1 expression pattern in either ILK
 
fl/
 
 
 
,Cre (Fig.
5 G) or ILK
 
fl/fl
 
,Cre (Fig. 5 H) E16.5 embryos. Since the nor-
mal spatial and temporal pattern of expression of chondro-
cyte differentiation markers was maintained in ILK
 
fl/fl
 
,Cre
embryos, we conclude that the mutation did not affect
chondrocyte differentiation.
 
Normal apoptosis in ILK
 
fl/fl
 
,Cre growth plates
 
The normal differentiation pattern of chondrocytes from IL-
K
 
fl/fl
 
,Cre embryos suggested that the observed dwarfism phe-
notype could be due to decreased chondrocyte proliferation
and/or increased apoptotic rates. We examined the effect of
ILK inactivation on expression levels of caspase-cleaved cy-
tokeratin, a marker of apoptosis. In the growth plate, apop-
tosis is restricted to regions of terminal differentiation, the
prehypertrophic and hypertrophic zones. There was no dif-
ference in the staining for caspase-cleaved cytokeratin in the
prehypertrophic and hypertrophic zones between mutant
and control animals (Fig. 6, A and B). The proliferative zone
of the growth plate from animals of all genotypes did not
stain for the apoptosis marker (Fig. 6, A and B). This data
indicates that chondrocyte apoptosis is not influenced by
ILK inactivation.
 
Reduced proliferation of ILK
 
fl/fl
 
,Cre chondrocytes
 
We assessed chondrocyte proliferation by quantifying BrdU
and proliferating cell nuclear antigen (PCNA) labeling in
the growth plate of femurs from 4-d-old animals. There was
a significant reduction in the percentage of PCNA- (Fig. 6
G) and BrdU- (Fig. 6 H) positive cells in the proliferating
zone of the distal femoral growth plate of ILK
 
fl/fl
 
,Cre mice
compared with the same region in ILK
 
fl/
 
 
 
,Cre control mice.
Cyclin D1 is an important regulator of the cell cycle, since it
promotes the transduction of the G1 phase to the S phase
(Inoshita et al., 1999). The expression of cyclin D1 has also
been shown to be regulated by ILK (Radeva et al., 1997;
D’Amico et al., 2000; Persad et al., 2000), suggesting that
the reduced proliferation may be a consequence of reduced
cyclin D1 expression in the ILK mutant chondrocytes. In
ILK
 
fl/
 
 
 
,Cre control mice, cyclin D1 was abundantly ex-
pressed in the proliferating zone and showed a perinuclear
and cytosolic localization (Fig. 6 C; corresponding DAPI
stain in E). However, in ILK
 
fl/fl
 
,Cre mutant animals, levels
of cyclin D1 protein were greatly reduced in the proliferat-
Figure 5. Normal differentiation of ILK-deficient chondrocytes. 
In situ hybridization of growth plate from control (fl/ , Cre, A, C, E, 
and G) or mutant (fl/fl, Cre, B, D, F, and H) E16.5 mouse femur. 
(A and B) Collagen type II (col II), antisense probe. (C and D) Collagen 
type X (col X), antisense probe. (E and F) Ihh, antisense probe. 
(G and H) PTHR1, antisense probe. The zone of expression is 
bracketed in E–H. Note that these markers of differentiation exhibit 
the same pattern of expression in control and mutant littermates. 
Background staining with sense probes was undetectable (not 
depicted). Bars, 100  m.T
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ing zone (Fig. 6 D). DAPI staining confirmed the presence
of cyclin D1–negative chondrocytes in the proliferating zone
of the ILK-deficient growth plate (Fig. 6 F). There was no
positive staining for cyclin D1 in hypertrophic chondrocytes
from growth plates of either genotype, although some speck-
led background signal could be observed in some sections
(unpublished data).
We also measured reduced proliferation rates in primary
cultures of chondrocytes from ILK
 
fl/fl
 
,Cre mutant mice when
compared with wild-type or ILK
 
fl/
 
 
 
,Cre genotypes (Fig. 6 I).
Together, these data demonstrate that inactivating both ILK
alleles significantly inhibited chondrocyte proliferation.
 
Impaired adhesion of ILK
 
fl/fl
 
,Cre chondrocytes to 
collagen type II
 
Primary cultures of costochondral chondrocytes were de-
rived to further characterize the effects of the inactivation of
ILK in these cells. Initially, adhesion to extracellular matrix
components was measured. Chondrocytes of all genotypes
adhered poorly to the BSA-coated negative control plates
(Fig. 7). Wild-type chondrocytes (fl/fl and fl/
 
 
 
) adhered
strongly to collagen type II–coated dishes, and this charac-
teristic was not affected by the expression of the Cre trans-
gene in heterozygous floxed chondrocytes (Fig. 7, fl/
 
 
 
,Cre).
Primary chondrocytes isolated from ILK
 
fl/fl
 
,Cre mice (fl/
fl,Cre), however, were severely hampered in their capacity to
attach to a collagen type II substratum (Fig. 7). This was not
due to reduced expression of 
 
 
 
1
 
-integrins (unpublished
data). Adhesion of ILK
 
fl/fl
 
,Cre chondrocytes to fibronectin
was also reduced (unpublished data). Thus, perturbing sig-
naling downstream from integrins impaired chondrocyte ad-
hesion to extracellular matrix molecules.
 
Discussion
 
To investigate the importance of signaling downstream from
integrins in growth plate chondrocytes, we have specifically
Figure 6. Normal apoptosis and reduced expression of proliferation 
markers in mutant (fl/fl, Cre) mice. (A and B) Immunostaining 
of caspase-cleaved cytokeratin 18. A comparable signal can be 
observed in control (A) and mutant fl/fl,Cre (B) mice. (C and D) Indirect 
immunofluorescence staining with anti–cyclin D1 antibody of 
growth plate from neonatal mouse femur. (C) Control mouse 
(fl/ , Cre). (D) Mutant littermate (fl/fl, Cre). E and F show 
the DAPI signal for the fields shown in C and D, respectively. 
(G and H) Percentage of PCNA- (G) or BrdU- (H) positive cells in 
the growth plate of neonatal control and mutant mouse femurs. 
Mean   SEM of three sections from two control and two mutant 
mice are shown. *P   0.05; ***P   0.001. (I) Growth curves of 
control (fl/ ,Cre;  ) and mutant (fl/fl,Cre;  ) primary chondrocytes. 
Cells were seeded at low density and viable cells (trypan blue 
exclusion) were counted daily with a hemocytometer. Results 
are shown as the percentage of increase relative to number of 
cells seeded.
Figure 7. Reduced adhesion of ILK-deficient chondrocytes. 
Chondrocytes were harvested from the ribs of newborn mice 
and cultured for 2 d before labeling with 
35S-methionine and 
performing the adhesion assay. Adhesion is quantified by counting 
the radioactivity of labeled, adherent cells (in cpm). Background 
adhesion was measured using BSA-coated plates. The chondrocytes 
from mutant mice (fl/fl, Cre; black bars), which do not express ILK, 
are impaired in their capacity to bind a collagen type II matrix.T
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inactivated both alleles of ILK in collagen type II–expressing
chondrocytes using the Cre-lox technique. Our results
showed that ILK is highly expressed in proliferating and pre-
hypertrophic chondrocytes. Specific ablation of ILK in a
proportion of those cells in the growth plate led to dwarfism
and chondrodysplasia. Inactivation of both ILK alleles in
chondrocytes reduced adhesion and proliferation of the cells
without major effects on differentiation or apoptosis. There
was a marked reduction in cyclin D1 protein expression.
Overall, our data demonstrate the importance of ILK-medi-
ated signaling for chondrocyte proliferation and for main-
taining normal growth plate architecture and function.
Several groups have engineered transgenic strains that spe-
cifically express the Cre recombinase in type II collagen–
expressing chondrocytes (Ovchinnikov et al., 2000; Long et
al., 2001b; Schipani et al., 2001). The Col2-Cre strain that
we engineered achieved high levels of expression of the Cre
recombinase that led to efficient recombination at the R26R
locus. We observed variable efficiency of the recombination
event at the ILK locus. Nonetheless, the dwarfism and chon-
drodysplasia phenotype of ILK
 
fl/fl
 
,Cre mice was 100% pene-
trant. This suggests that inhibiting ILK-mediated signal trans-
duction in even a subpopulation of proliferating chondrocytes
is severely deleterious for growth plate structure and function.
The ILK
 
fl/fl
 
,Cre animals exhibited dwarfism with shorten-
ing of the limbs. The most striking effect of ILK inactiva-
tion was seen in the proliferating zone, with a reduced
height and abnormally round-shaped, disorganized cells.
Femur length of neonatal ILK
 
fl/fl
 
,Cre animals was smaller
than wild-type and ILK
 
fl/
 
 
 
,Cre controls. With increasing
age, the femur length of ILK
 
fl/fl
 
,Cre mice further negatively
diverged from controls. Thus, postnatal growth is severely
affected in mutants.
We observed normal spatial and temporal expression of
several differentiation markers of the chondrocyte pheno-
type, both during development (Fig. 5) and postnatally (un-
published data). In particular, Ihh expression was normal,
demonstrating that the reduced proliferation phenotype ob-
served in ILK
 
fl/fl
 
,Cre chondrocytes is not secondary to a per-
turbation of the Ihh signaling pathway. Ectopic expression
of collagen type X was not seen in mutant growth plates.
Furthermore, the hypertrophic region was not enlarged.
These findings indicate that the size reduction of the prolif-
erative zone was not caused by a higher differentiating rate
toward the hypertrophic chondrocyte fate. Similarly, we
found no major changes in apoptosis of developing chon-
drocytes. Therefore, shortening of the proliferative zone can-
not be explained by an increase in apoptotic rate.
The reduced height of the proliferative zone and the
dwarfism phenotype appeared mainly due to a significant
decrease in proliferation of collagen type II–expressing chon-
drocytes as demonstrated by the dramatic reduction in the
expression of the proliferation markers BrdU, PCNA, and
cyclin D1. The significant down-regulation of cyclin D1 ex-
pression in the ILK mutant chondrocytes suggests an essen-
tial role of ILK in the regulation of the expression of cyclin
D1 in chondrocytes. These data support previous findings
implicating ILK as a regulator of cyclin D1 expression
(Radeva et al., 1997; D’Amico et al., 2000; Persad et al.,
2001b). The expression of cyclin D1 by ILK has been shown
to be regulated at the transcriptional level and may involve
the activation of several transcription factors regulated by
the ILK signaling pathway. These transcription factors in-
clude activating protein-1, Tcf(LEF)/
 
 
 
-catenin, and cyclic
AMP response element binding protein (CREB), all of
which can bind to the cyclin D1 promoter and regulate tran-
scription from the cyclin D1 promoter. The precise signal-
ing pathways activated by ILK in the regulation of cyclin D1
expression may vary according to the cell type. Thus, al-
though ILK has been shown to regulate cyclin D1 expres-
sion in a GSK-3–dependent manner (D’Amico et al., 2000;
Persad et al., 2001b), the phosphorylation of GSK-3 
 
 
 
 on
serine 9, the kinase inactivation site, does not seem to be al-
tered in the ILK mutant chondrocytes (unpublished data). It
is possible that in chondrocytes ILK regulates cyclin D1 ex-
pression in a PKB/Akt-dependent but GSK-3–independent
manner. Cyclin D1 transcription is strongly regulated by
binding of CREB or activating transcription factor 2 to the
cAMP response element within its promoter (Watanabe et
al., 1996; Beier et al., 1999; D’Amico et al., 2000), and
CREB has been shown to be a target of the PKB/Akt kinase
activity (Du and Montminy, 1998). It is likely that the con-
trol of cyclin D1 transcription by ILK in chondrocytes in-
volves CREB and/or activating transcription factor 2, since
these transcriptional regulators have been shown to be im-
portant for cyclin D1 transcription in chondrocytes (Beier et
al., 1999) and for chondrocyte proliferation (Long et al.,
2001a). PKB/Akt can also regulate cyclin D1 transcription
by inactivation of the negative regulator of cyclin D1 expres-
sion, the FoxO forkhead transcription factors (Schmidt et
al., 2002). The precise mechanism of the ILK-mediated reg-
ulation of cyclin D1 expression in chondrocytes remains to
be elucidated.
In cultured cells, ILK has been shown previously to be a
major regulator of the phosphorylation of PKB/Akt on
serine 473 (Delcommenne et al., 1998; Persad et al., 2000,
2001a; Di-Poi et al., 2002). We have also used the floxed-
ILK mice described here to isolate macrophages from these
mice and knock-down ILK expression in these cells by ex-
pression of Cre recombinase using adenoviral infection
(Kaartinen and Nagy, 2001). In these cells, we not only ob-
serve a dramatic and specific inhibition of PKB/Akt serine
473 phosphorylation and down-regulation of cyclin D1 ex-
pression but also inhibition of GSK-3 phosphorylation on
serine-9 (Troussard et al., 2003), further supporting cell-
type specific regulation of GSK-3 phosphorylation by the
ILK-PKB/Akt pathway.
Recent data have shown that ILK can interact with several
proteins involved in coupling integrins to the actin cytoskel-
eton and localization of ILK to focal adhesion plaques (Wu
and Dedhar, 2001). The interaction of ILK with CH-
ILKBP and affixin regulates early stages of cell spreading.
Furthermore, ILK can interact with paxillin, and this inter-
action may be responsible for the localization of ILK to focal
adhesion plaques (Wu and Dedhar, 2001). Thus, in addi-
tion to its signaling properties as a kinase in the regulation of
PKB/Akt, GSK-3, and cyclin D1, ILK also functions as an
adaptor protein in coupling integrins to the actin cytoskele-
ton. ILK regulates cell adhesion and spreading via its inter-
actions with the integrin cytoplasmic domains and focal ad-T
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hesion plaque components mentioned above, and recent
genetic data from Drosophila and C. elegans (Zervas et al.,
2001; Mackinnon et al., 2002) provide strong support for
an essential role for ILK in the regulation of cell adhesion
and spreading. Our findings reported here that the ILK mu-
tant chondrocytes are defective in cell attachment and
spreading on type II collagen and fibronectin provide fur-
ther support for an essential role of ILK in the regulation of
cell attachment and spreading on extracellular matrix. The
disorganization of the chondrocytes in the ILK
fl/fl,Cre mice
may be a reflection of these altered cell attachment and
spreading properties.
It could be argued that the inhibition of cyclin D1 expres-
sion resulting from the loss of ILK expression is a conse-
quence of decreased attachment of the chondrocytes to the
extracellular matrix. However, this is unlikely to be the case
since we have shown recently that inhibition of integrin
function results in the inhibition of cell proliferation in an
ILK- and a PKB/Akt-dependent manner irrespective of ef-
fects on cell adhesion (Cruet-Hennequart et al., 2003). In
addition, ILK regulates PKB/Akt phosphorylation and cy-
clin D1 expression in an anchorage-independent manner in
cancer cells (Radeva et al., 1997; Attwell et al., 2000; Persad
et al., 2000, 2001b). ILK activity is also regulated by several
growth factors and chemokines (Delcommenne et al., 1998;
Wu and Dedhar, 2001; Friedrich et al., 2002) in addition to
cell adhesion. The chondrodysplasia observed as a conse-
quence of the down-regulation of ILK expression is there-
fore likely to be due to a combination of effects on cell at-
tachment and spreading and altered proliferation secondary
to impaired signal transduction.
While this manuscript was under revision, a similar study
was published by Grashoff et al. (2003). Their findings con-
firm the chondrodysplasia and decreased chondrocyte prolif-
eration and adhesion associated with ILK inactivation in
growth plate chondrocytes. Grashoff et al. (2003) reported
that all mice with chondrocyte-specific disruption of ILK
died at birth due to respiratory distress, whereas the mutant
ILK
fl/fl,Cre mice that we engineered survive to adulthood
with dwarfism. The somewhat less severe mutation that we
have engineered should allow to gain further insight into the
ILK signaling cascade and into the impact of chondrocyte-
specific ILK inactivation on the formation of the secondary
ossification center and postnatal bone growth and structure.
Materials and methods
Engineering of Cre transgenic line and conditional ILK knockout
The Col2-Cre transgenic strain was engineered by subcloning the full-
length cDNA of the bacterial Cre recombinase (Sauer and Henderson,
1990) between a 3-kb fragment of the  1(II) promoter and its 3-kb chon-
drocyte-specific enhancer region (Zhou et al., 1998). Transgenic founders
were generated by pronuclear injection according to standard protocols
(Hogan et al., 1994).
The full-length human ILK cDNA (Hannigan et al., 1996) was used as
probe to isolate a 15.5-kb murine ILK genomic clone from a 129Sv strain
DNA library (Stratagene). A nearly full-length 6.5-kb EagI/EcoRI fragment
was subcloned into pBluescript (Stratagene) to create the targeting vector.
From this starting vector, a 1,316-bp NsiI-SphI fragment encompassing
from the end of exon 4 to the middle of exon 10 was subcloned into
pBluescript and used to insert by inverse PCR a single 34-bp loxP site with
a BamHI restriction site downstream from exon 4. The loxP-containing
subfragment was then reinserted into the parental targeting vector. The
previously described ploxPGK-neoNTRtkpAloxP cassette (He et al., 2001)
was inserted by blunt end ligation into the single Eco47III site downstream
of exon 12.
R1 embryonic stem cells (Nagy et al., 1993) were electroporated with
the linearized targeting vector, and G418-resistant colonies were picked
and screened for homologous recombination by Southern blotting on
BamH1 digests. The probe used was an EagI-PstI 900-bp fragment from
downstream of the region of homology. Targeted ES cells were then trans-
fected with the Cre expression vector, pBS185 (Life Technologies), to ex-
cise the neo cassette. We confirmed the in vitro excision using Southern
blotting of Bam H1 genomic digests with the Eag1-Pst1 probe. The result-
ing loxP-flanked (floxed) ILK locus contained one loxP site downstream
from exon 4 and a second loxP site, in the same orientation, downstream
from exon 12 (Fig. 3 A). The injection of the embryonic stem cells carrying
the floxed ILK allele into C57BL/6 embryos at the blastocyst stage was per-
formed using standard methodology (Hogan et al., 1994).
Chondrocyte-specific inactivation of the ILK gene was accomplished by
mating mice containing the floxed ILK allele (genotype: ILK
fl/fl) to Col2-Cre
transgenic mice to generate mice bearing Col2-Cre and a floxed allele in
their germline (genotype: ILK
fl/ ,Cre). These were backcrossed to homozy-
gote floxed mice in the following cross: ILK
fl/ ,Cre X ILK
fl/fl to generate mice
with both alleles inactivated in chondrocytes (genotype: ILK
fl/fl,Cre). Rou-
tine genotyping of tail DNA samples (Laird et al., 1991) used the following
primer pairs: for the Cre transgene, 5 -CCTGGAAAATGCTTCTGTCCG-3 
and 5 -CAGGGTGTTATAACAATCCC-3 , yielding a 391-bp diagnostic
fragment. For monitoring the ILK genotype, the primers used were: 5 -
CCAGGTGGCAGAGGTAAGTA-3  and 5 -CAAGGAATAAGGTGAGCT-
TCAGAA-3 . These primers yielded amplimers of 1.9-kb, 2.1-kb, and, 230-
bp for the wild-type, floxed, and Cre-excised alleles, respectively (Fig. 3 D).
All mice were housed in a virus- and parasite-free barrier facility. They
were exposed to a 12-h light–dark cycle and fed tap water and regular
chow at libitum. All procedures involving animals were approved previ-
ously by the Institutional Animal Care and Use Committee.
Histology
Limbs were dissected, fixed overnight at 4 C in 4% PFA buffered in PBS,
decalcified in 25% EDTA at 37 C with daily changes until soft (Takeda et
al., 2001), dehydrated, embedded in paraffin, sectioned at 6  m, and
stained with toluidine blue.
Immunofluorescence staining
Sections from femurs of ILK
fl/ ,Cre and ILK
fl/fl,Cre mice were dewaxed and
rehydrated. To unmask antigens, we performed antigen retrieval using BD
Retrievagen A (BD PharMingen) for 10 min at 94 C with a cool down pe-
riod of 15 min. Sections were blocked using the MOM kit (Vector Lab-
oratories) followed by incubation with first antibodies overnight at 4 C
(dilution 1:50). Sections were incubated with fluorescein isothiocyanate-
conjugated secondary antibodies for 1–2 h at room temperature (dilution
1:200) and mounted in Vectashield (with DAPI) mounting medium (Vector
Laboratories). When necessary, the avidin-biotin amplification system was
used according to the manufacturer’s protocol (Vector Laboratories) to
gain more signal.
Antibodies directed against the following antigens were used: ILK (Up-
state Biotechnology Inc.), Cre-recombinase (Novagen), collagen type II
(Research Diagnostics Inc.), collagen type X (a gift from Dr. Eunice Lee,
Shriners Hospital for Children, Montreal, QC, Canada), caspase-cleaved
cytokeratin 18 (M30 CytoDeath kit; Roche Molecular Biochemicals), cy-
clin D1 (Santa Cruz Biotechnology, Inc.), and  1-integrin (Santa Cruz Bio-
technology, Inc.). Conjugated secondary antibodies were from Jackson Im-
munoResearch Laboratories.
In situ hybridization
Femurs from E16.5 embryos were dissected, fixed, and sectioned as de-
scribed above. In situ hybridization to sections was performed as de-
scribed by Wilkinson (1992) using digoxigenin-labeled riboprobes. Probes
were labeled using the MAXIscript in vitro transcription kit (Ambion) and
digoxigenin-UTP (Roche Molecular Biochemicals). Signal detection was
with the DIG nucleic acid detection kit (Roche). The probes used were de-
scribed before: Ihh (Bitgood and McMahon, 1995), a gift from Dr. Benoit
St-Jacques (Shriners Hospital) and PTHR1,  1(II) collagen, and  1(X) col-
lagen (Lee et al., 1996) provided by Dr. Henry Kronenberg (Harvard Medi-
cal School, Boston, MA).
Proliferation assay
Mice were injected with 50  g/g body weight i.p. of BrdU (Sigma-Aldrich)
1 h before sacrifice. Bone sections were stained with the BrdU staining kitT
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(Zymed Laboratories). Additional sections were stained with the PCNA
staining kit (Zymed Laboratories). Total and BrdU- or PCNA-positive chon-
drocytes were counted on two to four sections from 2 ILK
fl/ ,Cre and 2 IL-
K
fl/fl,Cre mice. Statistical significance was assessed using Student’s t test,
and P   0.05 was considered significant.
Primary cultures of chondrocytes
Primary cultures of chondrocytes from rib growth plates of newborn mice
were prepared using the culture system developed by Lefebvre et al.
(1994). Briefly, the rib cage and sternum were dissected from 1-d-old
mice, rinsed in PBS, and incubated at 37 C for 2 h in 2 mg/ml of collage-
nase D in Dulbecco’s Minimal Essential Medium (DMEM). Soft tissues
were detached from the cartilage by repeated gentle up and down pipet-
ting. The denser cartilage was allowed to sediment, and the soft tissues
were aspirated; the cartilage was then further digested with collagenase D
for 3 h. Undigested bony parts were discarded, and the remaining cell sus-
pension was aspirated repeatedly with a Pasteur pipette, filtered through a
70- m cell strainer (Falcon; Becton Dickinson), rinsed first in PBS then in
serum-free DMEM, and counted. Chondrocytes were seeded in 6-well
plates at a density of 700,000 cells per well in DMEM with antibiotics,
ascorbic acid, and 10% FBS. Primary chondrocytes prepared under these
conditions retain their differentiated phenotype for several days in culture
(Lefebvre et al., 1994). Proliferation of the primary chondrocytes was as-
sessed by plating cells at low density (5,000 cells/cm
2) in 24-well tissue
culture plates and counting the number of viable cells (trypan blue exclu-
sion) daily with a hemocytometer until confluence.
For the adhesion assay, chondrocytes were cultured for 2 d before la-
beling with 
35S-methionine (Seger et al., 2001) and performing the adhe-
sion assay on collagen type II–coated 24-well plates (Loeser et al., 2000).
Labeled cells were collected using 5 mM EDTA into serum-free medium,
centrifuged, and resuspended at 10
6 cells/ml into serum-free medium.
Cells in suspension (250  l) were added to each coated well for 30 min at
37 C. After washing, the adhered cells were treated with 0.5 ml 1% Triton
X-100 in PBS for 5 min. Adhesion was quantified by counting 0.4-ml ali-
quots from the adherent cells and expressed in cpm. Background adhesion
was measured using BSA-coated plates.
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animal care, and Guylaine Bédard prepared the figures.
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